Lenvatinib Mesylate CAS 857890-39-2

Lenvatinib Mesylate CAS 857890-39-2

CAS NO: 857890-39-2
Molecular Formula:C15H17N3O4
Molecular Weight: 303.313
Chat Now

Product Details

Product Description:

Product Name: Lenvatinib mesylate CAS NO:857890-39-2



4-[3-chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide mesylate;


Chemical & Physical Properties:

Appearance: white powder

Assay :≥99.0%



Lovatinib mesylate is the mesylate of levatinib. Lovatinib is a multi-target tyrosine kinase inhibitor developed by Eisai Japan. It has a novel binding mode. In addition to inhibiting other pro-angiogenic and oncogenic signaling pathways related tyrosine kinases involved in tumor proliferation, it can also selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors, such as VEGF-1, VEGF-2 and VEGF- 3 etc.


If you are interested in our products or have any questions, please feel free to contact us!



Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.




Hot Tags: lenvatinib mesylate cas 857890-39-2, manufacturers, suppliers, factory, buy, in stock, 3-Amino-6-methylbenzenesulfonamide, CAS 130912-52-6, 2,2,2-Trifluoroethylamine, 4-(Isopropylamino)Butan-1-ol, CAS 181289-33-8, 1-Tosyl-3-pyrrolidinone


You Might Also Like